Albumin for septic shock after surgery
Treatments studied
Part of Infections clinical trials.
This trial tests whether giving albumin (a protein in the blood) along with standard fluids helps patients with septic shock after a surgical infection. The goal is to see if it improves recovery and survival compared to fluids alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and are in the surgical intensive care unit (SICU).
- You have a surgical infection that needed surgery or a procedure within the last 48 hours.
- You are in septic shock: your blood pressure is very low despite fluids, or you need medications to keep it up for at least an hour, and you have signs of organ problems (like high lactic acid or low urine output).
- You do not have any condition that already requires albumin (such as severe liver disease, kidney problems with protein loss, or severe burns), and you are not allergic to albumin.
- You do not have signs of fluid overload (too much fluid in your body) or end-stage kidney disease on dialysis, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving albumin instead of standard crystalloid fluids helps adults with septic shock. It may improve how well your body circulates blood and reduces strain on organs.
This trial tests whether giving albumin (a blood protein through an IV) can improve recovery after acute kidney injury in people who are in the ICU and need kidney support treatment. It mainly aims to help the kidneys bounce back better after this serious illness.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.
This study tests whether therapeutic plasma exchange (a procedure that removes and replaces blood plasma) can improve outcomes in ICU patients with septic shock that is not responding to standard medicines. It may help some people whose infection-related illness is causing failing organs.
This trial tests whether giving albumin, a protein in the blood that helps keep fluid in the vessels, can improve outcomes for people with sepsis-related lung injury (ARDS) who are on a breathing machine. If you have low albumin levels, this therapy might help your lungs recover.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.